nobivac dhppi

For the prevention of canine distemper (CDV), canine infectious hepatitis caused by canine adenovirus type 1 (ICH), canine parvovirus disease (CPV), and respiratory disease caused by canine parainfluenza (CPi) and canine adenovirus type 2 (CAV2) in dogs, there is a live attenuated vaccine.

Each dose contains live, attenuated strains of the following:
107 TCID50 for Canine Parvo virus (strain C 154)
104 TCID50 for Canine Distemper virus (Onderstepoort strain).
104 TCID50 for Canine Adenovirus Type 2 (Strain Manhattan LPV3)
Cornell strain of the canine parainfluenza virus has a TCID50 of 105.5.

Vaccination against CDV, CAV2, CPV, and CPi is an indication. The vaccination guards against infectious canine hepatitis (ICH), which is brought on by CAV1, in addition to protecting against CAV2 disease entities like respiratory tract infections.

Reconstitute the contents of one vial of Nobivac DHPPi for dosage and administration.